Cargando…
Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010–2019
INTRODUCTION: A potentially elevated risk for pulmonary thrombosis with Janus kinase inhibitors (JAKinibs) was identified, as well as an increased risk for portal vein thrombosis, in ruxolitinib patients. Consequently, the objective of this investigation was to repeat a comprehensive analysis of the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280037/ https://www.ncbi.nlm.nih.gov/pubmed/34120321 http://dx.doi.org/10.1007/s40264-021-01082-y |